AGER and Hepatic fibrosis: The effects of RAGE and its ligands can be amplified in various diseases, such as vascular disease, diabetes, cancer, hepatic fibrosis, chronic airway disease, and neurodegenerative disease (Han et al., 2011; Zhao et al., 2014; Xia et al., 2015; Chen et al., 2016).